Major Milestone For Our Portfolio Company Inura Medical, Who Closes Their Pre-series A Financing Round

Inura Medical’s mission is to improve women’s health through the development of an urethral ovulum for the treatment of patients suffering from urinary bladder diseases. Their first pharmaceutical product is addressing an unmet medical need in overactive bladder (OAB). 

Our portfolio company HexagonFab secures CHF 2.5m seed funding to speed discovery and production of the next-gen of biopharmaceuticals!

HexagonFab, a spin-out from the University of Cambridge, has developed a novel approach for drug discovery and production process monitoring called the Bolt. This innovative device is an analytical lab instrument that provides convenient and affordable access to molecular binding analytics.

Hemex and youEngineering announce strategic partnership

We’re thrilled to announce an exciting new partnership between HEMEX and YouEngineering, a software engineering company which aims to foster digital progress. Our latest partnership enables us to provide healthcare start-ups with a new range of digital packages to guarantee our clients the best results in mobile app, software development, and web design.

Hemex and Avanti Europe announce new partnership

HEMEX is delighted to announce an exciting new partnership with Avanti Europe. The
Avanti Europe team is a specialist consultancy and expert knowledge provider. This
partnership will allow us to complete the range of products we provide to healthcare start-ups to ensure we continue offering excellent support within the life science industry.

A Game-changing Device for Fall and Emergency Detection

An era may have come to an end; however, the dawn of a completely new investor showcase format is just over the horizon, and with it, many incredible investment opportunities which promise to revolutionise our healthcare landscape. Stay tuned; more information is heading your way soon!

Macu4 to Revolutionize the Passive-arm Prosthetics Market

Every other Thursday, HEMEX showcases smart ideas and solutions from innovation-driven start-ups that aim to improve our future healthcare services. This morning, we had the pleasure of hosting a very special HEMEX Investment Showcase, where project lead, Dr. Myriam Lingg, brilliantly presented macu4’s innovative idea to revolutionize the passive-arm prosthetics market.

InQbator: A new start-up incubator and accelerator powered by BLKB, Hemex, and Launchpad

BLKB, Hemex and Launchpad aim to support young entrepreneurs in their business activities through the start-up incubator program, inQbator. The program is open to start-ups from all industries. The main aim of inQbator is to promote innovation in the region.